Phiome
PrivateLast Round
Series D
Sep 10, 2024
Total Funding Raised
$303.5M
Company Overview
Phiome is a biotechnology company that specializes in odour preventative technology using microbiome-smart ingredients for cosmetic and textile applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, D2C Brands
Business Model
B2B
Customer Profile
Data as a Service, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phiome Comparables
Compare Phiome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AOBiome Therapeutics Inc. | 71% | |
| Arcaea | 70% | |
| Beiersdorf | 70% |
Phiome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 10, 2024 | ||||
| Series C Extension | Aug 18, 2023 | ||||
| Series C Extension | Oct 18, 2022 | ||||
| Convertible Debt | Nov 10, 2021 | ||||
| Series B | Nov 1, 2019 | ||||
Series A | Aug 2, 2017 |
Phiome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ocgrow Ventures | Convertible Debt, Series C Extension |
| Ezaki Glico Co., Ltd. | Convertible Debt, Series B, Series C Extension |
| Khosla Ventures | Convertible Debt, Series B, Series C Extension, Series D, Series A |
| WestRiver Group | Series B |
| BOLD Capital Partners | Convertible Debt, Series B, Series D, Series A, Series C Extension |
| WestRiver Group | Convertible Debt, Series C Extension, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 10, 2024
$25M round with Khosla Ventures and BOLD Capital Partners.
- Aug 18, 2023
$87M round led by Khosla Ventures and BOLD Capital Partners.
Phiome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Phiome's valuation, stock price, and market status.
Is Phiome a public or private company?
Phiome is a private company.
What is the current stock price of Phiome?
Phiome is a private company with no public stock price. No recent secondary market data is available.
How much is Phiome worth (valuation)?
Valuation information for Phiome is not publicly available.
Can I buy Phiome stock?
Phiome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Phiome's last funding round?
Phiome's most recent funding round was Series D on September 10, 2024.
Who are the main investors in Phiome?
Key investors in Phiome include Khosla Ventures, BOLD Capital Partners.
Will Phiome IPO soon?
No public IPO plans have been announced for Phiome.
How can I track Phiome secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Phiome's secondary market activity and sign up for updates.